Trademark
Full logoAbout DexCom
Dexcom is a leading maker of continuous glucose monitors (CGMs) for people with type 1 and type 2 diabetes, anchored by the Dexcom G7 — its sixth-generation sensor — and the Stelo over-the-counter CGM launched in 2024 for adults without diabetes. Headquartered in San Diego, California and founded in 1999, the company competes primarily with Abbott's FreeStyle Libre in the CGM market. CGMs have been one of the fastest-growing medical device categories of the past decade, driven by expansion from intensive insulin therapy into broader diabetes populations and wellness use cases.
About the DexCom logo
The DexCom (DXCM) logo is part of the Tickericons pack — a hand-crafted set of logos for every company in the S&P 500. Each logo is manually redrawn to a consistent grid, weight, and corner radius so DXCM sits cleanly next to other tickers in cap tables, dashboards, equity research, and fintech UI.
You get two styles: the trademark (just the symbol, ideal for grids and tight UI) and the full logo (mark plus wordmark, ideal when there's room to breathe). Both ship as scalable SVG, high-resolution PNG, and reusable Figma components.
Is DexCom in the S&P 500?
Yes. DexCom (DXCM) is a member of the S&P 500 and has been since May 12, 2020. It is classified under the Health Care sector. See every S&P 500 addition and removal.
Index history
May 12, 2020 · Added to the S&P 500
Allergan acquired by AbbVie.
Other Health Care companies
See all →
abtAbbott LaboratoriesMar 4, 195725,459
abbvAbbVieDec 31, 20125,068
aAgilent TechnologiesJun 5, 20009,660
algnAlign TechnologyJun 19, 20173,437
amgnAmgenJan 2, 199212,737
baxBaxter InternationalSep 30, 197219,770
bdxBecton Dickinson and CoSep 30, 197219,770
techBio-Techne CorporationAug 30, 20211,904
biibBiogenNov 13, 20038,404
bsxBoston Scientific CorporationFeb 24, 199511,588
Get all S&P 500 logos
One-time payment. SVG, PNG, and a Figma library. Free updates as the index changes.


